Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01254929 · ClinicalTrials.gov registry record
F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases
A clinical trial of Cancer and Bone Metastases, sponsored by Seattle Nuclear Medicine.
- Completed
- Registry status
- 299
- Enrollment target
- 1
- Study location
NCT01254929 is a study of Cancer and Bone Metastases that has completed, run by Seattle Nuclear Medicine. The registered enrollment target is 299 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01254929, a study of Cancer and Bone Metastases, has completed, sponsored by Seattle Nuclear Medicine.
- COMPLETED
- Registry status
- 299 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare 18F-Fluoride PET bone scans to traditional 99mTc-MDP bone scan to determine if one is better for diagnosing bone metastases.
Conditions Studied
Interventions
- DEVICE F-18 PET bone scan
- DEVICE Tc-99m bone scan
Study Locations (1)
Washington
- Seattle Nuclear Medicine - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 299 participants |
| Start Date | 2010-12 |
| Est. Completion | 2020-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01254929
The ClinicalTrials.gov registry entry for NCT01254929 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 299 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (91% lower). The listed sponsor is Seattle Nuclear Medicine, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which F-18 PET bone scan is the first listed.
NCT01254929 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT01254929 about?
NCT01254929 is a clinical study titled "F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases". The purpose of this study is to compare 18F-Fluoride PET bone scans to traditional 99mTc-MDP bone scan to determine if one is better for diagnosing bone metastases.
What is the current status of trial NCT01254929?
This trial is currently completed. The enrollment target is 299 participants. The study started on 2010-12. Estimated completion is 2020-03.
What conditions does trial NCT01254929 study?
This clinical trial studies the following conditions: Cancer, Bone Metastases.
What interventions are being tested in trial NCT01254929?
The interventions under investigation include: F-18 PET bone scan (DEVICE), Tc-99m bone scan (DEVICE).
Who is sponsoring clinical trial NCT01254929?
This trial is sponsored by Seattle Nuclear Medicine, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01254929 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.